AERI

Aerie Pharmaceuticals Stock Price

15.23
-0.28 (-1.81%)
Upgrade to Real-Time
Regular Market
15.23

Low
9.01

52 Week Range

High
21.30

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Aerie Pharmaceuticals Inc AERI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.28 -1.81% 15.23 13:34:06
Open Price Low Price High Price Close Price Prev Close
15.58 15.12 15.70 15.51
Bid Price Ask Price Spread News
15.23 15.25 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,111 86,753 $ 15.33 $ 1,329,617 - 9.01 - 21.30
Last Trade Time Type Quantity Stock Price Currency
13:36:16 6 $ 15.235 USD

Period:

Draw Mode:

Aerie Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 714.18M 46.89M 45.81M $ 83.14M $ - -3.98 -4.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 66.85k 2.40%

more financials information »

Aerie Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AERI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.0916.2214.9515.69334,5590.140.93%
1 Month18.8418.9014.9215.80423,869-3.61-19.16%
3 Months16.87519.2614.9116.61511,355-1.65-9.75%
6 Months18.1121.3014.9117.46565,488-2.88-15.9%
1 Year13.1221.309.0114.53632,9472.1116.08%
3 Years71.4071.559.0123.90753,730-56.17-78.67%
5 Years17.1774.759.0131.22664,199-1.94-11.3%

Aerie Pharmaceuticals Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roclatan. The company mainly operates in North America.


Your Recent History
NASDAQ
AERI
Aerie Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.